Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce that it has entered into a Memorandum of Understanding (MoU) with the Instruments division of Essilor International, a subsidiary of EssilorLuxottica. Essilor International is the world’s leading ophthalmic optics… Continue reading Diagnos $ADK #DGNOF Signs Memorandum of Understanding with #Essilor International
Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce the official opening of the initial clinics at the Magrabi Hospital. Dr. Ibrahim Al-Omar, Undersecretary of the Ministry of Health for Investment, inaugurated last Wednesday the early detection unit… Continue reading Diagnos $ADK $DGNOF Announces the Opening of the #AI Assisted #Screening #Clinic at #Magrabi #Hospital with the Presence of the Undersecretary of the Ministry of #Health of #SaudiArabia
Diagnos Inc. $ADK $DGNOF #AI #healthcare #technology #diabetics #blindness #StrokePrevention Interview: https://youtu.be/B7elDQ7bgb4 InvestorIntel Interview with Andre Larente, President of Diagnos Inc.
Diagnos Inc. TSXV-ADK OTCQB: DGNOF a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the signing of an exclusive distribution agreement with Diagnos Europe GmbH (“Diagnos Europe”), a new partner for DIAGNOS to tackle the strategically important DACH countries in the European… Continue reading Diagnos $ADK $DGNOF Enters into Exclusive Distribution Agreement to Access Massive Global Healthcare Market in DACH Countries and Central Europe of Over 140 Million People